StockTipsArenaBeta

Piramal Pharma Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹244.54-0.53 (-0.22%)
As of 13 Nov 2026

Avg 1-year target

All 6 long-term calls are BUY

₹286.6717.2% above today's price

Piramal Pharma's average 1-year share price target is ₹286.67, the average of 6 advisors' latest targets. Targets range from ₹270 to ₹310.

Latest: Shrikant Chouhan, Kotak Securities ₹310 · 9 Nov 2026

9
9 BUY · 0 SELL, all horizons
6
with an active 1Y target
64%
35 of 55 closed calls hit
65
all horizons, open and closed
Watch PPLPHARMA for new buy/sell callsGet alertsSee 53 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips · page 2 of 2

← Back to filtered view
BUYTarget₹190
DSbyDharmesh Shah, ICICI SecuritiesTarget hit
1–2 Weeks* · 20 Jul 2026 · entry ₹176.5 · via LiveMint Marketsexit ₹190
BUYTarget₹188.5
ICbyIDBI CapitalTarget hit
1–2 Weeks* · 16 Jul 2026 · entry ₹176.45 · via IDBI Capital Research Calls Telegramexit ₹188.5
BUYTarget₹230
SRbySiddharth Rai MangalaStop-loss hit
1–2 Weeks* · 21 Sept 2026 · entry ₹215.6 · via Zee Business (Live)exit ₹209
BUYTarget₹219
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 21 Sept 2026 · entry ₹211 · via IDBI Capital Research Calls Telegramexit ₹207
BUYTarget₹236
AKbyArun Kumar MantriStop-loss hit
1–2 Weeks · 8 Sept 2026 · entry ₹227 · via CNBC Awaaz.exit ₹221
BUYTarget₹245
KSbyKshitija Salvi, Globe Capital MarketStop-loss hit
1–2 Weeks* · 7 Sept 2026 · entry ₹219.82 · via CNBC Awaaz.exit ₹213
BUYTarget₹250
PHbyPradip Hotchandani, Prudent Corporate Advisory ServicesStop-loss hit
1–2 Weeks* · 28 Aug 2026 · entry ₹218.76 · via CNBC Awaaz.exit ₹211
BUYTarget₹223
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 20 Aug 2026 · entry ₹213 · via IDBI Capital Research Calls Telegramexit ₹208
BUYTarget₹193
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 21 Jul 2026 · entry ₹183 · via IDBI Capital Research Calls Telegramexit ₹178
BUYTarget₹195
SMbySomil Mehta, SharekhanStop-loss hit
1–2 Weeks* · 3 Jul 2026 · entry ₹176.6 · via CNBC Awaaz.exit ₹168
BUYTarget₹195
RDbyRupak De, LKP SecuritiesStop-loss hit
1–2 Weeks* · 3 Jul 2026 · entry ₹178.4 · via Zee Business (Live)exit ₹171
BUYTarget₹195
RDbyRupak De, LKP SecuritiesStop-loss hit
1–2 Weeks* · 11 May 2026 · entry ₹184.5 · via CNBC Awaaz.exit ₹179
BUYTarget₹220
VKbyVishnu Kant Upadhyay, Master Capital ServicesExpired
1–2 Weeks* · 21 Jul 2026 · entry ₹184.81 · via Business Todayexit ₹202.14
BUYTarget₹219
RBbyRakesh BansalStop-loss hit
Intraday* · 24 Sept 2026 · entry ₹214 · via CNBC Awaaz.exit ₹209
BUYTarget₹222
KHbyKunal Hasmukhlal ShahExpired
Intraday* · 2 Sept 2026 · entry ₹217.25 · via Zee Business (Live)exit ₹213.98

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks

Showing 51–65 of 65